Zoetis inc stock.

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);ZTS Sales vs. its Competitors Q3 2023. Comparing the current results to its competitors, Zoetis Inc reported Revenue increase in the 3 quarter 2023 by 7.44 % year on year. The revenue growth was below Zoetis Inc 's competitors' average revenue growth of 7.44 %. Select the Relationship:In the previous week, Boston Scientific had 6 more articles in the media than Zoetis. MarketBeat recorded 12 mentions for Boston Scientific and 6 mentions for Zoetis. Boston Scientific's average media sentiment score of 1.32 beat Zoetis' score of 0.64 indicating that Zoetis is being referred to more favorably in the news media.Pfizer owns 400,985,000 shares of Zoetis Class B common stock, which represents approximately 80.2% of the outstanding common stock of Zoetis. Prior to completion of the exchange offer, Pfizer intends to convert its Zoetis Class B common stock into Zoetis Class A common stock in an amount sufficient such that Zoetis Class A …Zoetis (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis | Nyse: ZTS | Nyse

May 12, 2023 · Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), BP p.l.c. (BP) and Zoetis Inc. (ZTS).

The company reported revenue of $2.0 billion for the third quarter of 2022, an increase of 1% compared with the third quarter of 2021. Net income for the third quarter of 2022 was $529 million, or $1.13 per diluted share, a decrease of 4% and 3%, respectively, on a reported basis. On an operational 1 basis, revenue for the third quarter of 2022 ...Welcome to Zoetis. As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. test.

Oct 14, 2021 · Zoetis Declares Fourth Quarter 2021 Dividend. PARSIPPANY, N.J.-- (BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share. The dividend is to be paid on Wednesday, December 1, 2021, to holders of record on Friday, October ... The Zoetis stock price fell by -0.667% on the last day (Wednesday, 29th Nov 2023) from $176.97 to $175.79. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.61% from a day low at $175.24 to a day high of $178.06. The price has risen in 6 of the last 10 days and is up by 1.82% over the past 2 weeks.Zoetis Inc. (ZTS) Stock Price | Stock Quote Nyse - MarketScreener ZOETIS INC. Zoetis Inc. Stock price Equities ZTS US98978V1035 Pharmaceuticals …Nov 4, 2021 · PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2021 and increased its guidance for full year 2021. The company reported revenue of $2.0 billion for the third quarter of 2021, an increase of 11% compared with the third quarter of 2020. Historical daily share price chart and data for Zoetis since 2013 adjusted for splits and dividends. The latest closing stock price for Zoetis as of November 24, 2023 is 180.21. …

The estimated Net Worth of William C Jr Steere is at least $6.34 millió dollars as of 20 May 2021. Mr. Steere owns over 16,170 units of Zoetis Inc stock worth over $6,013,788 and over the last 20 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc.

Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...

2 nov 2023 ... Zoetis Inc. reports revenue of $2.2 billion, growing 7% in Q3 2023. Net income increases 13% to $596 million. Adjusted net income reaches ...PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Solensia ™ to control the pain of osteoarthritis (OA) in cats, helping improve their mobility, comfort and overall well-being. 1 As a once-monthly injection administered in the veterinary clinic, …Price Performance Review of ZTS. On Friday, Zoetis Inc [NYSE:ZTS] saw its stock fall -0.99% to $174.80. On the same session, the stock had its day’s lowest price of $173.695, but rose to a high of $177.70. Over the last five days, the stock has gained 3.24%. Zoetis Inc shares have risen nearly 19.28% since the year began.What is Zoetis Inc (ZTS)'s stock price today? The current price of ZTS is $175.79. The 52 week high of ZTS is $194.99 and 52 week low is $140.76. When is next earnings date of Zoetis Inc (ZTS)?At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ...Zoetis has repurchased $545m of its stock in Q1-3, equivalent to 0.8% of its current market capitalization. Out of a $3.5bn share repurchase program authorized in December 2021, $3.0bn remained at ...The low in the last 52 weeks of Zoetis stock was 140.76. According to the current price, Zoetis is 125.08% away from the 52-week low. What was the 52-week high for Zoetis stock?The estimated Net Worth of Paul Bisaro is at least $36.9 Milion dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $12,501,674 and over the last 11 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.

May 5, 2022 · Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022.

74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Zoetis Inc. (ZTS) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 179.13 +2.46 (+1.39%) At close: 04:00PM EST 180.00... Zoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted …Find the latest Earnings Report Date for Zoetis Inc. Class A Common Stock (ZTS) at Nasdaq.com.Zoetis has repurchased $545m of its stock in Q1-3, equivalent to 0.8% of its current market capitalization. Out of a $3.5bn share repurchase program authorized in December 2021, $3.0bn remained at ...As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers ...Corporate Overview. As the world’s leading animal health company, Zoetis exists to nurture our world and humankind by advancing care for animals. With 70 years of experience innovating a leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies, we stand by those caring for animals by providing solutions worldwide.Zoetis is a component of the S&P 500 and has roughly 13,800 employees. Analyst Report: Zoetis Inc Zoetis Inc., a 2013 spinoff from Pfizer, focuses on the development, manufacture and ...The estimated Net Worth of Catherine A. Knupp is at least $17 Million dollars as of 10 November 2021. Catherine Knupp owns over 10,000 units of Zoetis Inc stock worth over $7,610,292 and over the last 11 years he sold ZTS stock worth over $6,035,956. In addition, he makes $3,311,220 as Executive Vice President und President - Research …

Real-time Price Updates for Zoetis Inc Cl A (ZTS-N), along with buy or sell indicators, analysis, charts, historical performance, news and more

As of July 25, 2023, Zoetis Inc (NYSE:ZTS) is witnessing a gain of 3.01%, with its stock price standing at $191.16. The company, with a market cap of $88.3 billion and sales of $8.1 billion, is ...

Zoetis shares fell 11% on the day of Q3 results, as investors reacted to a 3.7% decline in its Adjusted EPS. See why we reiterate our buy rating on ZTS stock.Dec 1, 2023 · Grading Zoetis Inc Stock. Before you choose to buy, sell or hold Zoetis Inc stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement. Zoetis Inc. Class A Common Stock (ZTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Analyst Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium Austria Israel TürkiyeWith stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ... The intrinsic value of one ZTS stock under the Base Case scenario is 114.51 USD. Compared to the current market price of 179.13 USD, Zoetis Inc is Overvalued by ...Zoetis Inc. Oct 2019 - Present 4 years 2 months. Tampa/St. Petersburg, Florida Area. Oversees the general office operations. Assist with new hires by collecting data to create profiles for the ...Zoetis Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Zoetis Inc. Stock | ZTS | US98978V1035The estimated Net Worth of Paul Bisaro is at least $38.1 millió dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.On 2023-11-30, Zoetis Inc (ZTS-N) stock closed at a price of $176.67. You may also like: RBI-T TYG-N MGT-T PBI-N BCPC-Q XST-T TARO-Q CRDF-Q JRCC-Q AKG-T Your Watchlist Add stocks to watchlist to monitor them daily and get important alerts. Get Access To Watchlist Get Access To Watchlist Latest ...

Financial Performance: Zoetis Inc has shown a strong financial performance with a steady increase in revenue and net income. The company's revenue increased by 5% from $6,040 million in the first ...Insider Activity at Zoetis. In other Zoetis news, EVP Heidi C. Chen sold 9,905 shares of the firm’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of ...Nov 4, 2021 · PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2021 and increased its guidance for full year 2021. The company reported revenue of $2.0 billion for the third quarter of 2021, an increase of 11% compared with the third quarter of 2020. Instagram:https://instagram. options paper trading platformindividual dental insurance ohiochefs wearhousehow much does discovery plus cost Dec 3, 2023 · Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats ... stock market worst monthsgrowing weed hydroponically Insider Activity at Zoetis. In other Zoetis news, EVP Heidi C. Chen sold 9,905 shares of the firm’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of ...The estimated Net Worth of Paul Bisaro is at least $37.6 Milión dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,215,457 and over the last 11 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc. florida va loans The estimated Net Worth of Paul Bisaro is at least $37.6 Milión dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,215,457 and over the last 11 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Zoetis Inc. (ZTS) Outperforms Peers and Shows Promising Growth: A Strong Buy Recommendation November 3, 2023TipRanks. Zoetis price target lowered to $255 from $260 at Barclays November 3 ...Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,152,608 and over the last 11 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc. Wallmine is a …